Retail attention spikes as EchoStar shorts retreat for third week

Seven days before earnings, EchoStar is attracting an unusual combination of signals: short interest at 15.4% of free float, down 11.3% week-on-week, retail attention running 2.97 standard deviations above its 90-day average, and options skewed firmly toward calls. The stock has added 10.0% over the past week, against a median gain of roughly 0.5% for its closest peers.

Three weeks of covering, still a large book

Short interest has fallen in each of the past three weeks. It stood near 19.6% of free float in mid-October. It is now 15.4%. That is a meaningful reduction, but 15.4% remains a high absolute level. Shorts have not abandoned the position; they have trimmed it systematically as the November 10 earnings date approaches.

The borrow market reflects the same dynamic. Availability has tightened to 151%, down from 182% a week ago and from above 230% in mid-October. That tightening is a function of demand absorbing the lending pool, not a cost-driven squeeze: cost to borrow sits at 0.51%, near the low end of its recent range. The 52-week low on availability was 7.5%, so the market is nowhere near a structural borrow squeeze, but the direction is clear.

Options and retail confirm the shift

The put/call ratio closed at 0.46 on November 2, 1.98 standard deviations below its 20-day mean of 0.49. That is the lowest defensive reading in 52 weeks. Options positioning has rotated steadily toward calls since early October, when the PCR was running above 0.53.

On the same day, retail attention hit a z-score of 2.97 above its own 90-day average, per Wikipedia page views and ORTEX stock page data. This is a spike in retail focus, not a revenue or earnings indicator, but the timing alongside a sharp price move and short covering is notable colour.

Analyst backdrop and what to watch

JP Morgan upgraded ECHO to Overweight from Underweight on October 16, setting a $144 target. That followed UBS lifting its rating to Buy in September with a $150 target and Morgan Stanley assuming coverage at Overweight with a $134 target. The consensus stands at buy, with a mean price target of $130.20, against a current price of $98.23.

ORTEX's short score sits at 71.5, roughly in the middle of its recent range, reflecting that the position is large but moving in one direction.

The date that resolves most of the open questions is November 10. Earnings history shows the stock moved 8.9% on the day following its August 3 print. With short interest still at 15.4% of float and five days of cover remaining in the FINRA fortnightly data, how the short book repositions into and out of that print is the central thing to watch.

---

• Short interest: 15.4% of free float, down 11.3% week-on-week, third consecutive weekly decline
• Borrow availability: 151%, down from 182% a week ago; 52-week low 7.5%
• Cost to borrow: 0.51%, low, stable
• Put/call ratio: 0.46, 1.98 standard deviations below 20-day mean, 52-week low
• Retail attention (Wikipedia + ORTEX page views): 2.97 standard deviations above 90-day average as of November 3
• Price: $98.23, up 10.0% over the past week; peer median +0.5%
• Next earnings: November 10